[1]
|
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M.R. and Balice-Gordon, R. (2011) Clinical Experience and Laboratory Investigations in Patients with Anti-NMDAR Encephalitis. The Lancet Neurology, 10, 63.
|
[2]
|
Florance, N.R., Davis, R.L., Lam, C., et al. (2009) Anti-N-methyl-Daspartate Receptor (NMDAR) Encephalitis in Children and Adolescents. Annals of Neurology, 66, 11-18. http://dx.doi.org/10.1002/ana.21756
|
[3]
|
Iizuka, T., Sakai, F., Ide, T., et al. (2008) Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome without Tumor Removal. Neurology, 70, 504-511. http://dx.doi.org/10.1212/01.wnl.0000278388.90370.c3
|
[4]
|
Zalel, Y., Piura, B., Elchalal, U., Czernobilsky, B., Antebi, S. and Dgani, R. (1996) Diagnosis and Management of Malignant Germ Cell Ovarian Tumours in Young Females. International Journal of Gynecology & Obstetrics, 55, 1-10.
|
[5]
|
Dalmau, J., Gleichman, A.J., Hughes, E.G., et al. (2008) Anti-NMDA-Receptor Encephalitis: Case Series and Analysis of the Effects of Antibodies. The Lancet Neurology, 7, 1091-1098. http://dx.doi.org/10.1016/S1474-4422(08)70224-2
|
[6]
|
Dalmau, J., Tuzun, E., Wu, H.Y., et al. (2007) Paraneoplastic Anti-N-Methyl-D-aspartate Receptor Encephalitis Associated with ovarian teratoma. Annals of Neurology, 61, 25-36. http://dx.doi.org/10.1002/ana.21050
|
[7]
|
Glaser, C.A., Honarmand, S., Anderson, L.J., et al. (2006) Beyond Viruses: Clinical Profiles and Etiologies Associated with Encephalitis. Clinical Infectious Diseases, 43, 1565-1577. http://dx.doi.org/10.1086/509330
|
[8]
|
Redington, J.J. and Tyler, K.L. (2002) Viral Infections of the Nervous System, 2002: Update on Diagnosis and Treatment. Archives of Neurology, 59, 712-718. http://dx.doi.org/10.1001/archneur.59.5.712
|
[9]
|
Hinson, V.K. and Tyor, W.R. (2001) Update on Viral Encephalitis. Current Opinion in Neurology, 14, 369-374. http://dx.doi.org/10.1097/00019052-200106000-00017
|